For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Ablation is an advanced treatment option for various diseases such as cancers, cardiac arrhythmias, and other medical conditions. Ultrasonic ablation is a noninvasive procedural technique that uses sound wave and is concentrated at the diseased area of the tissue, leading to heating and cellular destruction of the diseased tissue. Ultrasonic or magnetic resonance imaging (MRI) is performed that directs the ablation device to the diseased tissue. Ultrasonic tissue ablation system is designed. Radiofrequency and ultrasonic ablation devices are considered the most preferred and selected products by doctors and physicians. Ultrasonic ablation is a minimally invasive surgical procedure that involves a local anesthetic and mild sedation. This procedure is primarily used to reduce chronic low-back and neck pain caused due to degeneration of joints (due to arthritis and other spinal conditions).
Scope of the Report:
Region wise, the global ultrasonic tissue ablation systems market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America is estimated to account for major share as according to world health organization, growth rate of geriatric population will be higher in developed nations, especially in the U.S., Japan, and several countries in Europe. According to the U.S. Census Bureau, around 89 million people would be aged over 65 years in the U.S. by 2050. Furthermore, around 40% people in Japan would be aged over 65 years by 2060. Significant economic development has led to an increase in healthcare availability in Asia Pacific region providing an opportunity for ultrasonic tissue ablation devices companies to penetrate Asia Pacific regions. The rapid increase in the geriatric population is likely to fuel the growth of the ultrasonic ablation devices market during the forecast period.
The worldwide market for Ultrasonic Tissue Ablation System is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Ultrasonic Tissue Ablation System in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Johnson & Johnson
- Misonix Inc.
- SonaCare Medical, LLC.
- INSIGHTEC Ltd
- Integra LifeSciences Corporation
- Alpinion Medical Systems Co., Ltd.
- Chongqing Haifu Medical Technology Co., Ltd
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- High-intensity Focused Ultrasonic (HIFU) Ablators
- Magnetic Resonance-guided Focused Ultrasonic (MRGFUS) Ablators
- Ultrasonic Surgical Ablation Systems
- Shock wave therapy Systems
Market Segment by Applications, can be divided into
- Ambulatory Surgical Centers
- Specialty Care Unit
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ultrasonic Tissue Ablation System product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Ultrasonic Tissue Ablation System, with price, sales, revenue and global market share of Ultrasonic Tissue Ablation System in 2017 and 2018.
Chapter 3, the Ultrasonic Tissue Ablation System competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ultrasonic Tissue Ablation System breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Ultrasonic Tissue Ablation System market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Ultrasonic Tissue Ablation System sales channel, distributors, customers, research findings and conclusion, appendix and data source.